Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies (Q36098649)

12 August 2017

1 reference

title

Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies (English)

1 reference

12 August 2017

1 reference

4

Udo Sechtem

1 reference

12 August 2017

1

Heiko Mahrholdt

1 reference

12 August 2017

Anja Wagner

2

1 reference

12 August 2017

Robert M Judd

series ordinal

3

1 reference

12 August 2017

Raymond J Kim

series ordinal

5

1 reference

12 August 2017

publication date

14 April 2005

1 reference

12 August 2017

published in

European Heart Journal

1 reference

12 August 2017

volume

26

1 reference

12 August 2017

issue

15

1 reference

12 August 2017

page(s)

1461-1474

1 reference

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

The management of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Feasibility of diagnosing chronic myocarditis by endomyocardial biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Assessment of myocardial viability by cardiovascular magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

A standardized definition of ischemic cardiomyopathy for use in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Relaxation of water protons in the intra- and extracellular regions of blood containing Gd(DTPA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Relationship of elevated 23Na magnetic resonance image intensity to infarct size after acute reperfused myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Recognition of the importance of embolization in atherosclerotic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Cardiovascular magnetic resonance in cardiac amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI258

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHI258

1 reference

12 August 2017

1 reference